K-Beauty at CES: Tech-Driven Cosmetics vs. Pharma’s Clinical Credibility
Creatrip Team
2 months ago
South Korea’s beauty industry is shifting from product-driven cosmetics to tech, data and clinical evidence. At CES 2026, many K-beauty firms showcased AI, home-care devices and apps that measure skin and track results—turning creams into part of a management protocol. Examples include AI skin diagnostics and devices that treat or dispense agents. Meanwhile, Korean pharmaceutical companies are entering beauty by leveraging clinical trust: they market derma cosmetics and skin-regeneration ingredients backed by R&D and clinical testing. The two approaches—beauty brands proving effects with technology and devices, and pharmas persuading consumers with clinical data—are reshaping competition toward measurable outcomes and scientific evidence. (CES: Consumer Electronics Show)
